Financhill
Sell
22

ALLO Quote, Financials, Valuation and Earnings

Last price:
$1.82
Seasonality move :
-11%
Day range:
$1.79 - $1.90
52-week range:
$1.78 - $5.78
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3,853.42x
P/B ratio:
0.82x
Volume:
2.2M
Avg. volume:
2.9M
1-year change:
-42.22%
Market cap:
$381.6M
Revenue:
$95K
EPS (TTM):
-$1.56

Earnings Data

Next earnings date for ALLO
Mar 14
2025
Most recent earnings per share
-$0.32
Beat by $0.00
(Nov 7/2024)
Consensus Estimate
-$0.32
(Nov 7/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ALLO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $4.2K -- -- -$0.35 --
03/14/2025 Q4 $9.9K -- -- -$0.33 --
11/07/2024 Q3 $10K -- -$0.32 -$0.32 $0.00
08/07/2024 Q2 $893.9K -- -$0.35 -$0.35 -$0.00
05/13/2024 Q1 $10.4K $22K -$0.38 -$0.41 $0.03
03/14/2024 Q4 $22.4K $21K -$0.51 -$0.44 -$0.07
11/02/2023 Q3 -- -- -$0.37 -$0.52 $0.15
08/02/2023 Q2 -- -- -$0.53 -$0.59 $0.06
05/03/2023 Q1 -- -- -$0.68 -$0.62 -$0.06
02/28/2023 Q4 -- -- -$0.66 -$0.69 $0.03
11/02/2022 Q3 -- -- -$0.58 -$0.65 $0.07
08/09/2022 Q2 -- -- -$0.52 -$0.61 $0.09
05/04/2022 Q1 -- -- -$0.56 -$0.58 $0.02
02/23/2022 Q4 -- -- -$0.54 -$0.59 $0.05
11/04/2021 Q3 -- -- -$0.57 -$0.56 -$0.01
08/04/2021 Q2 -- -- -$0.53 -$0.54 $0.01
05/05/2021 Q1 -- -- -$0.25 -$0.40 $0.15
02/25/2021 Q4 -- -- -$0.53 -$0.55 $0.02
11/04/2020 Q3 -- -- -$0.52 -$0.55 $0.03
08/05/2020 Q2 -- -- -$0.53 -$0.54 $0.01
05/06/2020 Q1 -- -- -$0.50 -$0.58 $0.08
02/27/2020 Q4 -- -- -$0.58 -$0.68 $0.10
11/05/2019 Q3 -- -- -$0.50 -$0.54 $0.04
08/07/2019 Q2 -- -- -$0.41 -$0.44 $0.03
05/07/2019 Q1 -- -- -$0.32 -$0.44 $0.12
03/08/2019 Q4 -- -- -$0.37 -$0.25 -$0.12
11/21/2018 Q3 -- -- -$0.43 -$0.39 -$0.04

Allogene Therapeutics Earnings Questions

  • How Much did Allogene Therapeutics Generate in Revenue Last Quarter?

    Allogene Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Allogene Therapeutics Beat Earnings Last Quarter?

    Allogene Therapeutics announced earnings per share of -$0.32 which represents a beat of analyst forecast a -$0.32 per share.

  • Is Allogene Therapeutics Profitable?

    Allogene Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Allogene Therapeutics EPS Next Year?

    Allogene Therapeutics's earnings are forecast to decrease from -$2.09 per share to -$1.31 per share next year representing a decrease of -37.12%.

  • When is Allogene Therapeutics's Earnings Date?

    Allogene Therapeutics's next earnings date is March 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will TJX Companies Stock Be in 10 Years?
Where Will TJX Companies Stock Be in 10 Years?

Off-price retail is as popular as ever thanks to social…

Will CVS Health Stock Recover?
Will CVS Health Stock Recover?

It’s been a treacherous journey for CVS Health Corporation (NYSE:CVS)…

Why Is AT&T Stock Dropping?
Why Is AT&T Stock Dropping?

The telecommunications giant AT&T Inc. (NYSE:T) has perhaps surprisingly eclipsed…

Stock Ideas

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 38x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 115x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
45
QMCO alert for Jan 16

Quantum [QMCO] is down 0% over the past day.

Buy
51
QRVO alert for Jan 16

Qorvo [QRVO] is down 0% over the past day.

Sell
31
ATEX alert for Jan 16

Anterix [ATEX] is down 0% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock